Approval · Notice of Compliance 3229 · 1998
LAMISIL: Notice of Compliance 3229
Issued September 15, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3229
- Date
- September 15, 1998
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for a new dosage form
- Therapeutic class
- Antifungal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LAMISIL | 02238703 | Marketed |
Medicinal ingredients
- TERBINAFINE HCL 1 PER